BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hayashida M, Miyoshi J, Mitsui T, Miura M, Saito D, Sakuraba A, Kawashima S, Ikegaya N, Fukuoka K, Karube M, Komagata Y, Kaname S, Okada AA, Fujimori S, Matsuura M, Hisamatsu T. Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease. J Gastroenterol Hepatol 2020;35:1340-6. [PMID: 31999379 DOI: 10.1111/jgh.14995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ledó N, Pethő ÁG. Gastrointestinal symptoms as first remarkable signs of ANCA-associated granulomatosis with polyangiitis: a case report and reviews. BMC Gastroenterol 2021;21:158. [PMID: 33832425 DOI: 10.1186/s12876-021-01730-8] [Reference Citation Analysis]
2 Hatemi G. A treat-to-target approach is needed for Behçet's syndrome. Curr Opin Rheumatol 2022;34:39-45. [PMID: 34710886 DOI: 10.1097/BOR.0000000000000854] [Reference Citation Analysis]
3 Wei YS, Feng K, Li SF, Hu TG, Linhardt RJ, Zong MH, Wu H. Oral fate and stabilization technologies of lactoferrin: a systematic review. Crit Rev Food Sci Nutr 2021;:1-18. [PMID: 33749401 DOI: 10.1080/10408398.2021.1900774] [Reference Citation Analysis]